Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Jerome who wrote (1411)	6/13/2014 7:46:13 AM
From: w0z	Read Replies (3) \| Respond to of 26536

With a company like FNSR I would have two questions that need to be answered. 1) Are the products produced by FNSR market leaders? 2) Do I have confidence in the current management team to continue owning this stock? 1. Yes. FNSR is growing market share in most segments and should continue to do so. Products and growth was not the issue this quarter but execution was. 2. Conditional yes. As long as Rawls remains I have confidence but at age 68 I'm not sure how much longer he'll stay. From listening to many CCs and presentations, I do not have the same confidence in Gertel...he's simply not on top of things like Rawls. There was a rumor in early April (see below) about CSCO wanting to buy FNSR for something like $27-28. Given Rawls' age, I wonder if he might seriously entertain handing over the reins to his largest customer and retiring. I do have concerns that this might cause problems with other FNSR customers who are CSCO competitors. fool.com

To: Jerome who wrote (1411)	6/13/2014 9:42:38 AM
From: Kirk ©	1 Recommendation Recommended By Jerome Respond to of 26536

I have yet to read the CC transcript.... I wanted to read what analysts said then listen/read the CC to hear /read what was said with that in mind.... Other considerations..... with a price under 20 the PE gets close to 10, and the PB gets to under 2...I've been through this with other stocks and it usually took about 2 quarters of earnings for a full recovery. I wonder how much management attention the Optium merger took.... often head butting and cost cutting (cutting redundancy) can take more time and be more painful than expected so the first year after a big merger/acquisition is hard to predict. By merging with Optium, Finisar added long-haul telecom and CATV products to their portfolio. Finisar is a vertically integrated “optics” company with low-cost manufacturing capabilities. Given there was no growth in the market (telecom) for the company they acquired, cuts would be more painful and expensive than anticipated.

To: Jerome who wrote (1411)	6/16/2014 2:12:42 AM
From: Kirk ©	Read Replies (1) \| Respond to of 26536

My European index funds are LOVING these juicy premiums paid to lower tax rates and relocate HQs outside the US. Medtronic to buy Covidien for $42.9 billion, rebase in Ireland REUTERS—9:11 PM ET 06/15/14 - U.S. medical device maker Medtronic Inc ( MDT) said on Sunday it had agreed to buy Covidien Plc ( COV) for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad. The deal will allow Medtronic ( MDT) to reduce its overall global tax burden. Boy, those short will wake up with a migraine. COV Industry Comparison: As of Friday, Market Capitalization = $32.47B